Anti-inflammatory polymeric coatings for implantable biomaterials and devices

Journal of Diabetes Science and Technology

Volumn 2, Issue 6, 2008, Pages 984-994

  Bridges, Amanda W ^a   García, Andrés J ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Anti inflammatory; Biomaterial; Coating; Host response; Implant; Polymer

Indexed keywords

EID: 78649991308     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200628     Document Type: Conference Paper

References (149)

1. Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31:81-110.
2. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004;25:5681-703.
3. Kottke-Marchant K, Anderson JM, Umemura Y, Marchant RE. Effect of albumin coating on the in vitro blood compatibility of Dacron arterial prostheses. Biomaterials. 1989;10(3):147-55.
4. Sutherland K, Mahoney JR 2nd, Coury AJ, Eaton JW. Degradation of biomaterials by phagocyte-derived oxidants. J Clin Invest. 1993;92(5):2360-7.
5. Zhao Q, Topham N, Anderson JM, Hiltner A, Lodoen G, Payet CR. Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking. J Biomed Mater Res. 1991;25(2):177-83.
6. Destouet JM, Monsees BS, Oser RF, Nemecek JR, Young VL, Pilgram TK. Screening mammography in 350 women with breast implants: prevalence and findings of implant complications. AJR Am J Roentgenol. 1992;159(5):973-8.
7. Ambrose CG, Clanton TO. Bioabsorbable implants: review of clinical experience in orthopedic surgery. Ann Biomed Eng. 2004;32(1):171-7.
8. Voronov I, Santerre J P, Hinek A, Callahan JW, Sandhu J, Boynton EL. Macrophage phagocytosis of polyethylene particulate in vitro. J Biomed Mater Res. 1998;39(1):40-51.
9. McGraw J, Hiebert GW, Steeves JD. Modulating astrogliosis after neurotrauma. J Neurosci Res. 2001;63(2):109-15.
10. Wisniewski N, Moussy F, Reichert, WM. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem. 2000;366(6-7):611-21.
11. Vroman L, Adams AL, Klings M. Interactions among human blood proteins at interfaces. Fed Proc. 1971;30(5):1494-502.
12. Xu LC, Siedlecki CA. Effects of surface wettability and contact time on protein adhesion to biomaterial surfaces. Biomaterials. 2007;28(22):3273-83.
13. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng. 2005;11(1-2):1-18.
14. Collier TO, Anderson JM. Protein and surface effects on monocyte and macrophage adhesion, maturation, and survival. J Biomed Mater Res. 2002;60(3):487-96.
15. Shen M, Garcia I, Maier RV, Horbett TA. Effects of adsorbed proteins and surface chemistry on foreign body giant cell formation, tumor necrosis factor alpha release and procoagulant activity of monocytes. J Biomed Mater Res A. 2004;70(4):533-41.
16. Tang L, Eaton JW. Fibrin (ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 1993;178(6):2147-56.
17. Tang L, Liu L, Elwing HB. Complement activation and inflammation triggered by model biomaterial surfaces. J Biomed Mater Res. 1998;41(2):333-40.
18. Tang L, Lucas AH, Eaton JW. Inflammatory responses to implanted polymeric biomaterials: role of surface-adsorbed immunoglobulin G. J Lab Clin Med. 1993;122:292-300.
19. Hu WJ, Eaton JW, Ugarova TP, Tang L. Molecular basis of biomaterialmediated foreign body reactions. Blood. 2001;98(4):1231-8.
20. McNally AK, Anderson JM. Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci U S A. 1994;91(21):10119-23.
21. Wu Y, Simonovsky FI, Ratner BD, Horbett TA. The role of adsorbed fibrinogen in platelet adhesion to polyurethane surfaces: a comparison of surface hydrophobicity, protein adsorption, monoclonal antibody binding, and platelet adhesion. J Biomed Mater Res A. 2005;74(4):722-38.
22. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673-87.
23. McNally AK, Anderson JM. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol. 2002;160(2):621-30.
24. Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003;9(6):263-8.
25. Thomsen P, Gretzer C. Macrophage interactions with modified material surfaces. Current Opinion in Solid State and Materials Science. 2001;5(2-3):163-76.
26. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79(2):319-26.
27. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35.
28. Mosser DM. The many faces of macrophage activation. J Leukoc Biol. 2003;73(2):209-12.
29. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164(12):6166-73.
30. Chen EH, Grote E, Mohler W, Vignery A. Cell-cell fusion. FEBS Lett. 2007;581(11):2181-93.
31. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86-100.
32. Henson PM. The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. J Immunol. 1971;107(6):1547-57.
33. Henson PM. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol. 1971;107(6):1535-46.
34. Mathur AB, Collier TO, Kaw WJ, Wigging M, Schubert MA, Hiltner A, Anderson JM. In vivo biocompatibility and biostability of modified polyurethanes. J Biomed Mater Res. 1997;36(2):246-57.
35. Gerritsen M, Jansen JA, Kros A, Nolte RJ, Lutterman JA. Performance of subcutaneously implanted glucose sensors: a review. J Invest Surg. 1998;11(3):163-74.
36. Kyrolainen M, Rigsby P, Eddy S, Vadgama P. Bio-/haemocompatibility: implications and outcomes for sensors? Acta Anaesthesiol Scand Suppl. 1995;104:55-60.
37. Wisniewski N, Reichert M. Methods for reducing biosensor membrane biofouling. Colloids Surf B Biointerfaces. 2000;18(3-4):197-219.
38. Department of Health and Human Services, Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States. Atlanta; 2005.
39. Gilligan BJ, Shults MC, Rhodes RK, Updike SJ. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care. 1994;17(8):882-7.
40. Updike SJ, Shults MC, Rhodes RK, Gilligan BJ, Luebow JO, Von Heimburg D. Enzymatic glucose sensors. Improved long-term performance in vitro and in vivo. ASAIO J. 1994;40(2):157-63.
41. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care. 2000;23(2):208-14.
42. Luttikhuizen DT, Van Amerongen MJ, De Feijter PC, Petersen AH, Harmsen MC, Van Luyn MJ. The correlation between difference in foreign body reaction between implant locations and cytokine and MMP expression. Biomaterials. 2006;27(34):5763-70.
43. Andersson M, Suska F, Johansson A, Berglin M, Emanuelsson L, Elwing H, Thomsen P. Effect of molecular mobility of polymeric implants on soft tissue reactions: an in vivo study in rats. J Biomed Mater Res A. 2008;84(3):652-60.
44. Nair A, Zou L, Bhattacharyya D, Timmons RB, Tang L. Species and density of implant surface chemistry affect the extent of foreign body reactions. Langmuir. 2008;24(5):2015-24.
45. Geelhood SJ, Horbett TA, Ward WK, Wood MD, Quinn MJ. Passivating protein coatings for implantable glucose sensors: evaluation of protein retention. J Biomed Mater Res B Appl Biomater. 2007;81(1):251-60.
46. Amiji M, Park H, Park K. Study on the prevention of surfaceinduced platelet activation by albumin coating. J Biomater Sci Polym Ed. 1992;3(5):375-88.
47. Prichard HL, Reichert WM, Klitzman B. Adult adiposederived stem cell attachment to biomaterials. Biomaterials. 2007;28(6):936-46.
48. Kingshott P, Griesser HJ. Surfaces that resist bioadhesion. Current Opinion in Solid State and Materials Science. 1999;4(4):403-12.
49. Unsworth LD, Sheardown H, Brash JL. Polyethylene oxide surfaces of variable chain density by chemisorption of PEO-thiol on gold: adsorption of proteins from plasma studied by radiolabelling and immunoblotting. Biomaterials. 2005;26(30):5927-33.
50. Unsworth LD, Sheardown H, Brash JL. Protein-resistant poly (ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action. Langmuir. 2008;24(5):1924-9.
51. Michel R, Pasche S, Textor M, Castner DG. Influence of PEG architecture on protein adsorption and conformation. Langmuir. 2005;21(26):12327-32.
52. Morra M. On the molecular basis of fouling resistance. J Biomater Sci Polym Ed. 2000;11(6):547-69.
53. Szleifer I. Protein adsorption on tethered polymer layers: effect of polymer chain architecture and composition. Physica A. 1997;244(1-4):370-88.
54. Szleifer I. Polymers and proteins: interactions at interfaces. Current Opinion in Solid State and Materials Science. 1997;2(3):337-44.
55. Wang C, Yu B, Knudsen B, Harmon J, Moussy F, Moussy Y. Synthesis and performance of novel hydrogels coatings for implantable glucose sensors. Biomacromolecules. 2008;9(2):561-7.
56. Nolan CM, Reyes CD, Debord JD, García AJ, Lyon LA. Phase transition behavior, protein adsorption, and cell adhesion resistance of poly (ethylene glycol) cross-linked microgel particles. Biomacromolecules. 2005;6(4):2032-9.
57. Singh N, Bridges AW, García AJ, Lyon LA. Covalent tethering of functional microgel films onto poly (ethylene terephthalate) surfaces. Biomacromolecules. 2007;8(10):3271-5.
58. Yang Y, Zhang SF, Kingston MA, Jones G, Wright G, Spencer SA. Glucose sensor with improved haemocompatibilty. Biosens Bioelectron. 2000;15(5-6):221-7.
59. Iwasaki Y, Ishihara K, Nakabayashi N, Khang G, Jeon JH, Lee JW, Lee HB. Platelet adhesion on the gradient surfaces grafted with phospholipid polymer. J Biomater Sci Polym Ed. 1998;9(8):801-16.
60. Kudo H, Sawada T, Kazawa E, Yoshida H, Iwasaki Y, Mitsubayashi K. A flexible and wearable glucose sensor based on functional polymers with soft-MEMS techniques. Biosens Bioelectron. 2006;22(4):558-62.
61. Goreish HH, Lewis AL, Rose S, Lloyd AW. The effect of phosphorylcholine-coated materials on the inflammatory response and fibrous capsule formation: in vitro and in vivo observations. J Biomed Mater Res A. 2004;68(1):1-9.
62. Luk Y-Y, Kato M, Mrksich M. Self-assembled monolayers of alkanethiolates presenting mannitol groups are inert to protein adsorption and cell attachment. Langmuir. 2000;16(24):9604-8.
63. Holland NB, Qiu Y, Ruegsegger M, Marchant RE. Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers. Nature. 1998;392(6678):799-801.
64. Kane RS, Deschatelets P, Whitesides GM. Kosmotropes form the basis of protein-resistant surfaces. Langmuir. 2003;19(6):2388-91.
65. Prime KL, Whitesides GM. Adsorption of proteins onto surfaces containing end-attached oligo (ethylene oxide): a model system using self-assembled monolayers. J Am Chem Soc. 1993;115:10714-21.
66. Zhao B, Brittain WJ. Polymer brushes: surface-immobilized macromolecules. Prog Polym Sci. 2000;25:677-710.
67. Edmondson S, Osborne VL, Huck WT. Polymer brushes via surfaceinitiated polymerizations. Chem Soc Rev. 2004;33(1):14-22.
68. Kopecek J. Hydrogel biomaterials: a smart future? Biomaterials. 2007;28(34):5185-92.
69. Nath N, Chilkoti A. Creating "smart" surfaces using stimuli responsive polymers. Adv Mater. 2002;14(17):1243-7.
70. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002;54(1):3-12.
71. Mendelsohn JD, Yang SY, Hiller J, Hochbaum AI, Rubner MF. Rational design of cytophilic and cytophobic polyelectrolyte multilayer thin films. Biomacromolecules. 2003;4(1):96-106.
72. Nayak S, Lyon LA. Ligand-functionalized core/shell microgels with permselective shells. Angew Chem Int Ed Engl. 2004;43(48):6706-9.
73. Quinn CP, Pathak CP, Heller A, Hubbell JA. Photo-crosslinked copolymers of 2-hydroxyethyl methacrylate, poly (ethylene glycol) tetra-acrylate and ethylene dimethacrylate for improving biocompatibility of biosensors. Biomaterials. 1995;16(5):389-96.
74. Shen M, Martinson L, Wagner MS, Castner DG, Ratner BD, Horbett TA. PEO-like plasma polymerized tetraglyme surface interactions with leukocytes and proteins: in vitro and in vivo studies. J Biomater Sci Polym Ed. 2002;13(4):367-90.
75. Park HJ, Bae YH. Hydrogels based on poly (ethylene oxide) and poly (tetramethylene oxide) or poly (dimethyl siloxane). III. In vivo biocompatibility and biostability. J Biomed Mater Res A. 2003;64(2):309-19.
76. Ronneberger B, Kao WJ, Anderson JM, Kissel T. In vivo biocompatibility study of ABA triblock copolymers consisting of poly (L-lactic-co-glycolic acid) A blocks attached to central poly (oxyethylene) B blocks. J Biomed Mater Res. 1996;30(1):31-40.
77. Chapman RG, Ostuni E, Liang MN, Meluleni G, Kim E, Yan L, Pier G, Warren HS, Whitesides GM. Polymeric thin films that resist the adsorption of proteins and the adhesion of bacteria. Langmuir. 2001;17(4):1225-33.
78. Zhang F, Kang ET, Neoh KG, Huang W. Modification of gold surface by grafting of poly (ethylene glycol) for reduction in protein adsorption and platelet adhesion. J Biomater Sci Polym Ed. 2001;12(5):515-31.
79. Espadas-Torre C, Meyerhoff ME. Thrombogenic properties of untreated and poly (ethylene oxide)-modified polymeric matrices useful for preparing intraarterial ion-selective electrodes. Anal Chem. 1995;67(18):3108-14.
80. Lee JH, Jeong BJ, Lee HB. Plasma protein adsorption and platelet adhesion onto comb-like PEO gradient surfaces. J Biomed Mater Res. 1997;34(1):105-14.
81. Du H, Chandaroy P, Hui SW. Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim Biophys Acta. 1997;1326(2):236-48.
82. Zhang M, Desai T, Ferrari M. Proteins and cells on PEG immobilized silicon surfaces. Biomaterials. 1998;19(10):953-60.
83. Jenney CR, Anderson JM. Effects of surface-coupled polyethylene oxide on human macrophage adhesion and foreign body giant cell formation in vitro. J Biomed Mater Res. 1999;44(2):206-16.
84. Shen M, Pan YV, Wagner MS, Hauch KD, Castner DG, Ratner BD, Horbett TA. Inhibition of monocyte adhesion and fibrinogen adsorption on glow discharge plasma deposited tetraethylene glycol dimethyl ether. J Biomater Sci Polym Ed. 2001;12(9):961-78.
85. Otsuka H, Nagasaki Y, Kataoka K. Self-assembly of poly (ethylene glycol)-based block copolymers for biomedical applications. Current Opinion in Colloid and Interface Science. 2001;6(1):3-10.
86. Boulmedais F, Frisch B, Etienne O, Lavalle P, Picart C, Ogier J, Voegel JC, Schaaf P, Egles C. Polyelectrolyte multilayer films with pegylated polypeptides as a new type of anti-microbial protection for biomaterials. Biomaterials. 2004;25(11):2003-11.
87. Ma H, Hyun J, Stiller P, Chilkoti A. "Non-fouling" oligo (ethylene glycol)-functionalized polymer brushes synthesized by surfaceinitiated atom transfer radical polymerization. Adv Mater. 2004;16(4):338-41.
88. Ma H, Li D, Sheng X, Zhao B, Chilkoti A. Protein-resistant polymer coatings on silicon oxide by surface-initiated atom transfer radical polymerization. Langmuir. 2006;22(8):3751-6.
89. Zhou Y, Liedberg B, Gorochovceva N, Makuska R, Dedinaite A, Claesson PM. Chitosan-N-poly (ethylene oxide) brush polymers for reduced nonspecific protein adsorption. J Colloid Interface Sci. 2007;305(1):62-71.
90. Waku T, Matsusaki M, Kaneko T, Akashi M. PEG brush peptide nanospheres with stealth properties and chemical functionality. Macromolecules. 2007;40(17):6385-92.
91. Cao L, Chang M, Lee CY, Castner DG, Sukavaneshvar S, Ratner BD, Horbett TA. Plasma-deposited tetraglyme surfaces greatly reduce total blood protein adsorption, contact activation, platelet adhesion, platelet procoagulant activity, and in vitro thrombus deposition. J Biomed Mater Res A. 2007;81(4):827-37.
92. West JL, Hubbell JA. Comparison of covalently and physically cross-linked polyethylene glycol-based hydrogels for the prevention of postoperative adhesions in a rat model. Biomaterials. 1995;16(15):1153-6.
93. Quinn CA, Connor RE, Heller A. Biocompatible, glucose-permeable hydrogel for in situ coating of implantable biosensors. Biomaterials. 1997;18(24):1665-70.
94. Collier TO, Anderson JM, Brodbeck WG, Barber T, Healy KE. Inhibition of macrophage development and foreign body giant cell formation by hydrophilic interpenetrating polymer network. J Biomed Mater Res A. 2004;69(4):644-50.
95. Bridges AW, Singh N, Burns KL, Babensee JE, Lyon AL, García AJ. Reduced acute inflammatory responses to microgel conformal coatings. Biomaterials. 2008;29 (35) 4605-15.
96. Yu B, Wang C, Ju YM, West L, Harmon J, Moussy Y, Moussy F. Use of hydrogel coating to improve the performance of implanted glucose sensors. Biosens Bioelectron. 2008;23(8):1278-84.
97. Benkirane-Jessel N, Lavalle P, Meyer F, Audouin F, Frisch B, Schaaf P, Ogier J, Decher G, Voegel J-C. Control of monocyte morphology on and response to model surfaces for implants eqipped with anti-inflammatory agents. Adv Mater. 2004;16(17):1507-11.
98. Schultz P, Vautier D, Richert L, Jessel N, Haikel Y, Schaaf P, Voegel JC, Ogier J, Debry C. Polyelectrolyte multilayers functionalized by a synthetic analogue of an anti-inflammatory peptide, alpha-MSH, for coating a tracheal prosthesis. Biomaterials. 2005;26(15):2621-30.
99. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5-24.
100. Lutolf MP, Raeber GP, Zisch AH, Tirelli N, Hubbell JA. Cell-responsive synthetic hydrogels. Adv Mater. 2003;15(11):888-92.
101. Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N, Schmökel H, Bezuidenhout D, Djonov V, Zilla P, Hubbell JA. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J. 2003;17(15):2260-2.
102. Tauro JR, Gemeinhart RA. Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug Chem. 2005;16(5):1133-9.
103. Bae M, Cho S, Song J, Lee GY, Kim K, Yang J, Cho K, Kim SY, Byun Y. Metalloprotease-specific poly (ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis. Drugs Exp Clin Res. 2003;29(1):15-23.
104. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998;94(6):557-72.
105. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev. 1982;65:133-55.
106. Kiefer R, Kreutzberg GW. Effects of dexamethasone on microglial activation in vivo: selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus. J Neuroimmunol. 1991;34(2-3):99-108.
107. Norton LW, Koschwanez HE, Wisniewski NA, Klitzman B, Reichert WM. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res A. 2007;81(4):858-69.
108. Zhong Y, Bellamkonda RV. Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res. 2007;1148:15-27.
109. Kim DH, Martin DC. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials. 2006;27(15):3031-7.
110. Patil SD, Papadmitrakopoulos F, Burgess DJ. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release. 2007;117(1):68-79.
111. Wadhwa R, Lagenaur CF, Cui XT. Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J Control Release. 2006;110(3):531-41.
112. Anastase-Ravion S, Blondin C, Cholley B, Haeffner-Cavaillon N, Castellot JJ, Letourneur D. Heparin inhibits lipopolysaccharide (LPS) binding to leukocytes and LPS-induced cytokine production. J Biomed Mater Res A. 2003;66(2):376-84.
113. Salas A, Sans M, Soriano A, Reverter JC, Anderson DC, Piqué JM, Panés J. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut. 2000;47(1):88-96.
114. Du YJ, Brash JL, McClung G, Berry LR, Kelment P, Chan AK. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex. J Biomed Mater Res A. 2007;80(1):216-25.
115. Van Bilsen PH, Popa ER, Brouwer LA, Vincent J, Taylor CE, De Leij LF, Hendriks M, Van Luyn MJ. Ongoing foreign body reaction to subcutaneous implanted (heparin) modified Dacron in rats. J Biomed Mater Res A. 2004;68(3):423-7.
116. Rele SM, Cui W, Wang L, Hou S, Barr-Zarse G, Tatton D, Gnanou Y, Esko JD, Chaikof EL. Dendrimer-like PEO glycopolymers exhibit anti-inflammatory properties. J Am Chem Soc. 2005;127(29):10132-3.
117. Tseng PY, Rele SS, Sun XL, Chaikof EL. Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factorinduced thrombin generation in a flow model. Biomaterials. 2006;27(12):2637-50.
118. Zhong Y, Bellamkonda RV. Controlled release of anti-inflammatory agent alpha-MSH from neural implants. J Control Release. 2005;106(3):309-18.
119. Udipi K, Ornberg RL, Thurmond KB 2nd, Settle SL, Forster D, Riley D. Modification of inflammatory response to implanted biomedical materials in vivo by surface bound superoxide dismutase mimics. J Biomed Mater Res. 2000;51(4):549-60.
120. He W, McConnell GC, Schneider TM, Bellamkonda RV. A novel anti-inflammatory surface for neural electrodes. Adv Mater. 2007;19:3529-33.
121. Gerritsen M, Kros A, Sprakel V, Lutterman JA, Nolte RJ, Jansen JA. Biocompatibility evaluation of sol-gel coatings for subcutaneously implantable glucose sensors. Biomaterials. 2000;21(1):71-8.
122. Wang XH, Li DP, Wang WJ, Feng QL, Cui FZ, Xu YX, Song XH. Covalent immobilization of chitosan and heparin on PLGA surface. Int J Biol Macromol. 2003;33(1-3):95-100.
123. Sung WJ, Na K, Bae YH. Biocompatibility and interference eliminating property of pullulan acetate/polyethylene glycol/heparin membrane for the outer layer of an amperometric glucose sensor. Sens Actuators B Chem. 2004;99(2-3):393-8.
124. Fu J, Ji J, Yuan W, Shen J. Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. Biomaterials. 2005;26(33):6684-92.
125. Kim DH, Smith JT, Chilkoti A, Reichert WM. The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes. Biomaterials. 2007;28(23):3369-77.
126. Nguyen KT, Shaikh N, Shukla KP, Su SH, Eberhart RC, Tang L. Molecular responses of vascular smooth muscle cells and phagocytes to curcumin-eluting bioresorbable stent materials. Biomaterials. 2004;25(23):5333-46.
127. Su SH, Nguyen KT, Satasiya P, Greilich PE, Tang L, Eberhart RC. Curcumin impregnation improves the mechanical properties and reduces the inflammatory response associated with poly (L-lactic acid) fiber. J Biomater Sci Polym Ed. 2005;16(3):353-70.
128. Pan Ch J, Tang JJ, Weng YJ, Wang J, Huang N. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents. J Control Release. 2006;116(1):42-9.
129. Hahn SK, Jelacic S, Maier RV, Stayton PS, Hoffman AS. Antiinflammatory drug delivery from hyaluronic acid hydrogels. J Biomater Sci Polym Ed. 2004;15(9):1111-9.
130. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001;22(6):328-36.
131. Kao WJ, Liu Y, Gundloori R, Li J, Lee D, Einerson N, Burmania J, Stevens K. Engineering endogenous inflammatory cells as delivery vehicles. J Control Release. 2002;78(1-3):219-33.
132. Konstan MW, Davis PB. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis. Adv Drug Deliv Rev. 2002;54(11):1409-23.
133. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly (D, L-lactide-co-glycolide) and its derivatives. J Control Release. 2008;125(3):193-209.
134. Luten J, Van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release. 2008;126(2):97-110.
135. Lavi G, Dinarello CA, Apte RN, Cohen S. Sustained release of IL-1Ra from biodegradable microspheres prolongs its IL-1-neutralizing effects. Isr J Chemistry. 2005;45:457-64.
136. Rusanova AV, Makarova AM, Strukova SM, Markvicheva EA, Gorbachyova LR, Stashevskaya KS, Vasil'eva TV, Sidorova EI, Bespalova Zh D, Grandfils Ch. Thrombin receptor agonist Peptide immobilized in microspheres stimulates reparative processes in rats with gastric ulcer. Bull Exp Biol Med. 2006;142(1):35-8.
137. Yu P, Zheng C, Chen J, Zhang G, Liu Y, Suo X, Zhang G, Su Z. Investigation on PEGylation strategy of recombinant human interleukin-1 receptor antagonist. Bioorg Med Chem. 2007;15(16):5396-405.
138. Pierstorff E, Krucoff M, Ho D. Apoptosis induction and attenuation of inflammatory gene expression in murine macrophages via multitherapeutic nanomembranes. Nanotechnology. 2008;19 (26). [Epub ahead of print.]
139. Juliano R, Alam MR, Dixit V, Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res. 2008;36(12):4158-71.
140. Gary DJ, Puri N, Won YY. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release. 2007;121(1-2):64-73.
141. Mori R, Shaw TJ, Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med. 2008;205(1):43-51.
142. Andersen MØ, Howard KA, Paludan SR, Besenbacher F, Kjems J. Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials. 2007;29(4):506-12.
143. Chiarantini L, Cerasi A, Fraternale A, Millo E, Benatti U, Sparnacci K, Laus M, Ballestri M, Tondelli L. Comparison of novel delivery systems for antisense peptide nucleic acids. J Control Release. 2005;109(1-3):24-36.
144. Kovacs JR, Zheng Y, Shen H, Meng WS. Polymeric microspheres as stabilizing anchors for oligonucleotide delivery to dendritic cells. Biomaterials. 2005;26(33):6754-61.
145. Jeong JH, Kim SW, Park TG. Molecular design of functional polymers for gene therapy. Prog Polym Sci. 2007;32:1239-74.
146. Jewell CM, Zhang J, Fredin NJ, Wolff MR, Hacker TA, Lynn DM. Release of plasmid DNA from intravascular stents coated with ultrathin multilayered polyelectrolyte films. Biomacromolecules. 2006;7(9):2483-91.
147. De Fife KM, Shive MS, Hagen KM, Clapper DL, Anderson JM. Effects of photochemically immobilized polymer coatings on protein adsorption, cell adhesion, and the foreign body reaction to silicone rubber. J Biomed Mater Res. 1999;44(3):298-307.
148. Gil PR, Del Mercato LL, Del Pino P, Javier AM, Parak WJ. Nanoparticle-modified polyelectrolyte capsules. Nano Today. 2008;3(3-4):12-21.
149. Klueh U, Dorsky DI, Kreutzer DL. Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. Biomaterials. 2005;26(10):1155-63.